Carbohydrate-responsive element-binding protein (ChREBP) is a regulator of pancreatic b-cell gene expression and an important mediator of glucotoxicity. Glucose increases the activity and nuclear localization of ChREBP by still ill-defined mechanisms. Here we reveal, using both MIN6 and primary mouse b-cells, a unique mechanism behind ChREBP nuclear translocation. At low glucose concentrations, ChREBP interacts with sorcin, a penta EF hand Ca 2+ binding protein, and is sequestered in the cytosol. Sorcin overexpression inhibits ChREBP nuclear accumulation at high glucose and reduced the activity of L-type pyruvate kinase (L-PK) and TxNIP promoters, two well-characterized ChREBP target genes. Sorcin inactivation by RNA interference increases ChREBP nuclear localization and in vivo binding to the L-PK promoter at low glucose concentrations. Ca 2+ influx was essential for this process since Ca 2+ chelation with EGTA, or pharmacological inhibition with diazoxide and nifedipine, blocked the effects of glucose. Conversely, mobilization of intracellular Ca 2+ with ATP caused the nuclear accumulation of ChREBP. Finally, sorcin silencing inhibited ATP-induced increases in intracellular Ca 2+ and glucose-stimulated insulin secretion. We therefore conclude that sorcin retains ChREBP in the cytosol at low glucose concentrations and may act as a Ca 2+ sensor for glucose-induced nuclear translocation and the activation of ChREBP-dependent genes.
Nafeesa A. Noordeen, Gargi Meur, Guy A. Rutter, and Isabelle Leclerc Carbohydrate-responsive element-binding protein (ChREBP) is a regulator of pancreatic b-cell gene expression and an important mediator of glucotoxicity. Glucose increases the activity and nuclear localization of ChREBP by still ill-defined mechanisms. Here we reveal, using both MIN6 and primary mouse b-cells, a unique mechanism behind ChREBP nuclear translocation. At low glucose concentrations, ChREBP interacts with sorcin, a penta EF hand Ca 2+ binding protein, and is sequestered in the cytosol. Sorcin overexpression inhibits ChREBP nuclear accumulation at high glucose and reduced the activity of L-type pyruvate kinase (L-PK) and TxNIP promoters, two well-characterized ChREBP target genes. Sorcin inactivation by RNA interference increases ChREBP nuclear localization and in vivo binding to the L-PK promoter at low glucose concentrations. Ca 2+ influx was essential for this process since Ca 2+ chelation with EGTA, or pharmacological inhibition with diazoxide and nifedipine, blocked the effects of glucose. Conversely, mobilization of intracellular Ca 2+ with ATP caused the nuclear accumulation of ChREBP. Finally, sorcin silencing inhibited ATP-induced increases in intracellular Ca 2+ and glucose-stimulated insulin secretion. We therefore conclude that sorcin retains ChREBP in the cytosol at low glucose concentrations and may act as a Ca 2+ sensor for glucose-induced nuclear translocation and the activation of ChREBP-dependent genes. Diabetes 61:574-585, 2012 C arbohydrate-responsive element-binding protein (ChREBP) is a member of the basic helix-loophelix family of transcription factors and transactivates glucose-responsive genes by binding to DNA as a heterodimer with Max-like protein 31 at a well-defined carbohydrate-responsive element (1, 2) . ChREBP is responsible for converting excess carbohydrate to fatty acids for long-term storage (1) . Thus, ChREBP-null mice display diminished rates of hepatic glycolysis and lipogenesis resulting in high liver glycogen content, low plasma free fatty acid levels, and reduced adipose tissue mass (3) . Loss of ChREBP in ob/ob mice protects against obesity and hyperphagia (3, 4) . In the pancreatic b-cell, ChREBP overexpression (5) or silencing (6) results in the inhibition and stimulation, respectively, of glucose-stimulated insulin secretion (GSIS). These actions of ChREBP seem likely to be mediated through alterations in the deleterious effects of high glucose concentrations on b-cell function and survival, termed glucotoxicity. The latter process may involve the induction by ChREBP of lipogenic genes such as fatty acid synthase and L-type pyruvate kinase (L-PK) (6, 7) , as well as the proapoptotic gene thioredoxin interacting protein Txnip (8, 9) , and suppression of critical b-cell genes such as aryl hydrocarbon receptor nuclear translocator/hypoxia inducible factor-1b (ARNT/HIF-1b) (5), Pdx-1, MafA, glucokinase, and insulin (10) .
Translocation of ChREBP from the cytosol to the nucleus in response to elevated glucose concentrations has been documented in both liver (11) and clonal pancreatic b-cells (6, 12, 13) and is likely to be a key regulatory step in the activation of downstream genes. Although previous work in the pancreatic b-cell line INS1(832/13) has identified a glucose-sensing module in the NH 2 -terminal region (12, 13) , the exact mechanism(s) through which glucose prompts this subcellular relocalization are still unknown (14) .
Sorcin (soluble resistance-related calcium binding protein) is a 22 kDa protein, highly conserved among mammals and highly expressed in primary mouse islets (top 10th percentile of all messages as assessed by microarray and RNAseq data, G. Rutter, unpublished observations) that belongs to the penta-EF-hand family (15, 16) . In common with other members of this family, sorcin undergoes Ca 2+ -dependent conformational changes and translocation from cytosol to membranes where it binds to target proteins (17, 18) . In cardiac and skeletal muscle, sorcin interacts with the ryanodine receptor (RyR) (19) and with the pore-forming a 1 -subunit of voltage-dependent L-type Ca 2+ channels (20) . Sorcin has been shown to inhibit RyR activity (21) , and therefore to play a role in terminating the Ca 2+ -induced Ca 2+ release process (22, 23) , which would otherwise feed forward and deplete intracellular Ca 2+ stores (24) . It is noteworthy that sorcin phosphorylation by cAMP-dependent protein kinase (PKA) significantly decreases its ability to modulate RyR activity (21) .
Here we show that, in the excitable pancreatic b-cell, ChREBP is sequestered in the cytosol through sorcin binding at low glucose concentrations. Upon stimulation with glucose and activation of Ca 2+ influx, or application of ATP as an intracellular Ca 2+ -mobilizing agent, ChREBP rapidly translocates to the nucleus. In sorcin-silenced cells, ChREBP is constitutively present in the nucleus, and both glucose and Ca 2+ are ineffective in stimulating further ChREBP nuclear shuttling.
GAC GTC ATA TGG ATA GAC GGT CAT GAC ACA CTG GAT G-3, HA tag underlined, and subcloned at SalI and NotI sites of pcDNA3.1 + (Invitrogen). Plasmids 2183LPK.luci and 2148LPK.luci have been described in Ref. 26 . Plasmid 21081TXNIP.luci was obtained from Addgene and described in Ref. 27 . Adenovirus sorcin-HA, also expressing GFP from a single bicistronic mRNA under the cytomegalovirus (CMV) promoter, was generated by three-piece ligation of sorcin-HA and IRES-EGFP in pShuttle-CMV (28) using BglII, XhoI, and XbaI restriction sites. Adenovirus production was then performed as in Ref. 28 . Sorcin (sc-41017-v) and control (sc-108080) short hairpin RNA (shRNA) mouse lentiviruses were purchased from Santa Cruz. All constructs were verified by DNA sequencing. Cell culture and transfection. Human embryonic kidney 293, MIN6, and INS1 (832/13) cells were cultured as in Ref. 5 unless specified otherwise. Cells were transfected using Lipofectamine 2000 for plasmids and RNAiMAX for small interfering RNA (siRNA) (final concentration 2.5 to 5 nM) in Opti-Mem (Invitrogen). MIN6 b-cells cDNA library generation. MIN6 cDNA library was generated according to Matchmaker Library Construction and Screening Kit (Clontech) using Oligo d(T) primers, 2.0 mg total RNA, yeast strain AH109, and pGADT7-Rec AD. The transformants were selected on SD/-leu plates before yeast mating. Two-hybrid screen. Yeast two-hybrid was performed according to Matchmaker Gal4 Two-Hybrid System 3 (Clontech). In brief, yeast mating was performed using yeast strain AH109 containing the MIN6 cDNA library, and yeast strain Y187 was pretransformed with pGBKT7-ChREBP. Screens were conducted at high (-adenine/-histidine/-leucine/-tryptophan) stringency with 5 mmol/L 3-AT to prevent background growth. The library cDNAs contained in pGADT7 were identified by sequencing. Chromatin immunoprecipitation assay. MIN6 b-cells were transfected with scrambled or specific sorcin siRNA for 48 h. Chromatin immunoprecipitation was performed using anti-ChREBP antibody and mouse L-PK promoter primers as described (5, 6) . Nuclear-cytosolic protein extraction. MIN6 b-cells, nontransfected or transfected with sorcin-HA for 48 h, were cultured for 16 h in 3 mmol/L glucose followed by 6 h in 3 or 30 mmol/L glucose. The cells were scraped in icecold PBS, followed by centrifuging at 500g for 2 min. The cell pellets were lysed, and nuclear proteins were separated from the cytosolic fraction using the NucBuster Protein Extraction Kit (Novagen) before Western blotting. Luciferase assays. MIN6 b-cells seeded in 24-well plates were transfected with 1.5 mg of either 2183LPK.luci, 2148LPK.luci, or 21081TXNIP.luci reporter plasmids, 0.5 mg of either GFP or sorcin cDNA, and 1.5 ng of renilla luciferase to correct for transfection efficiency, using Lipofectamine 2000 (Invitrogen) and OPTI-MEM (5 mmol/L glucose) for 24 h followed by 25 mmol/L glucose Dulbecco's modified Eagle's medium for 24 h before cell lysis and luciferase assay using Dual-Luciferase Reporter Assay System (Promega). Immunostaining and confocal microscopy. MIN6 b-cells were fixed in 4% (volume for volume) paraformaldehyde, permeabilized with 0.3% Triton X-100, and stained with rabbit anti-c-myc antibody (1:250; Santa Cruz), and mouse anti-HA antibody (1:1000; 12CA5, Roche), followed by Alexa 488 conjugated goat anti-rabbit IgG and Alexa 568 conjugated donkey anti-mouse IgG (1:1,000; Invitrogen). Cells were imaged using a Zeiss Axoivert 200M microscope fitted with a PlanApo 363 oil immersion objective. Confocality was achieved using a Nipkow spinning disc under the control of Volocity 4.0 (Improvision) software. Measurement of free cystolic intracellular Ca ] cyt ) was calculated using a look-up table created from standard Ca 2+ solutions (Molecular Probes). Live-cell confocal imaging of ChREBP-EGFP. MIN6 b-cells were transfected either with ChREBP-EGFP plasmid alone or with sorcin siRNA for 48 h. Cells were then incubated overnight with 3 mmol/L glucose Dulbecco's modified Eagle's medium, and subsequently the coverslips were rinsed with 3 mmol/L glucose KRBH buffer and mounted on a hot stage with continuous perifusion with warm KRBH. Cells were imaged using a Zeiss Axiovert 200M microscope (Carl Zeiss, Jena, Germany) fitted with a PlanApo 633 oil-immersion objective and a 1.5 Optivar attached to a Nokigawa spinning disc confocal head. Hoechst (Invitrogen) staining of nuclei was visualized through DAPI filter. GFP-expressing samples were illuminated using steady-state 488 nm laser line, and emission was collected through ET535/30 emission filter (Chroma) for every 5 s. Images were captured using a Hamamatsu EM chargecoupled device digital camera, model C9100-13, controlled by Volocity 4.0 software. Deconvoluted images were analyzed by obtaining the gray values for every time point in the region of interest drawn around nucleus and the cytosol, which was then corrected for background and normalized, and ratios of nuclear to cytosolic distribution were generated. Preparation and imaging of dissociated mouse islets. Mouse islets were isolated (5) and partially dissociated by incubation in Hank's based cell dissociation buffer (Invitrogen) for 10 min by gentle pipetting. To assess the effects of intracellular Ca 2+ , primary cell clusters were transduced with c-myc-ChREBP-expressing adenoviral particles (also expressing GFP) (5) at a multiplicity of infection of ;50 for 6 h, followed by 48 h culture in fresh medium. Dissociated islets were then incubated overnight in 3 mmol/L glucose and thereafter in 3 or 17 mmol/L glucose in KRBH buffer containing either 1.5 mmol/L CaCl 2 or 10 mmol/L EGTA for 30 min and fixed in 4% paraformaldehyde for 10 min. After permeabilization with 0.1% Triton 3 100, immunostaining was carried out using the following antibodies: monoclonal anti-c-myc antibody (1:200; Roche), polyclonal anti-swine insulin (1:200; DakoCytomation, Ely, UK), and Alexa 564 or 633-coupled secondary antibodies (1:1,000; Molecular Probes), and coverslips were mounted in VECTASHIELD (Vector Laboratories) hardset medium with DAPI. Imaging was performed using a Leica SP2 upright confocal microscope with an HCX PL APO 633 1.32 numerical aperture oil immersion objective and the following laser lines: Argon ion (488 nm), HeNe (633 nm), 561 nm diode, and ultraviolet (350 nm) controlled by Leica LAS AF Lite software. Acquired images were analyzed using Volocity software (Improvision). To assess the effect of sorcin overexpression or silencing on endogenous ChREBP nuclear localization, dissociated islets were transduced with either sorcin (also expressing GFP) or GFP adenoviral particles as above or with shRNA sorcin or control lentiviral particles (Santa Cruz) according to the manufacturer's instructions in 11 mmol/L glucose RPMI 1640 for 48 h followed by 1 h in 3 mmol/L glucose RPMI 1640 and 6 h in 17 mmol/L glucose RPMI 1640. Cells were then fixed and immunostained using rabbit anti-ChREBP (1:100; Thermo Scientific) and mouse anti-sorcin (1:50; Invitrogen) and secondary goat-anti-rabbit Alexa 568, and goat-anti-mouse Alexa 633 (both at 1:1,000; Invitrogen). Insulin secretion and assay. MIN6 b-cells were transfected with sorcinspecific or scrambled siRNAs for 48 h before insulin secretion assay (5) . Statistical analysis. Data are given as mean 6 SEM of at least three individual experiments. Comparisons between means were performed using two-tailed Student t test for unpaired data, with Bonferroni correction and ANOVA.
RESULTS
ChREBP and sorcin are molecular binding partners under physiological conditions. We first detected sorcin as a ChREBP interactor in a yeast two-hybrid screen using full length ChREBP as bait in a pancreatic b-cell MIN6 library (not shown). We confirmed the interaction in mammalian cells by coimmunoprecipitation experiments of overexpressed c-myc-tagged ChREBP and HA-tagged sorcin in human embryonic kidney 293 cells ( Supplementary Fig. 1 ) and INS-1(832/13) b-cells (Fig. 1A, first lane from left) . This interaction was further delimited to the first 242 amino acids of ChREBP (Fig. 1A, second lane) , a region known as the low-glucose inhibitory domain (12) . Establishing the specificity of the ChREBP-sorcin interaction, coimmunoprecipitation experiments did not reveal any interaction between sorcin-HA and c-myc-Pdx-1 (Fig. 1A, fourth lane) , a transcription factor that also translocates to the nucleus in response to high glucose in this cell type (25) .
We next explored the interaction between endogenous ChREBP and sorcin in MIN6 cells. Such interaction was only detectable after crosslinking experiments, as shown in Fig. 1B . Indeed, crosslinking and immunoprecipitation with anti-sorcin antibody revealed a high molecular complex of ;140 kDa using both anti-sorcin (Fig. 1B, top panel, second and third lanes) and anti-ChREBP (Fig. 1B, bottom  panel, second and third lanes) antibodies. We believe this complex to represent sorcin dimers and ChREBP, since sorcin dimers were also detected after addition of the crosslinker (Fig. 1B, middle panel, second and third lanes) . Sorcin acts as a cytosolic anchor for ChREBP. It has been shown previously that ChREBP constantly shuttles between the cytosol and the nucleus (13) . The cytosolic retention domain has been mapped to the NH 2 -terminal region of ChREBP, since NH 2 -terminal deletion mutants lacking the first 252 amino acids are predominantly nuclear (12, 30, 31) .
Because sorcin interacts with ChREBP specifically through this domain (see Fig. 1A ), we next investigated whether sorcin may play a role in controlling the subcellular localization of ChREBP. With the use of spinning disc confocal microscopy, c-myc-ChREBP immunoreactivity was examined in MIN6 b-cells transfected with either c-mycChREBP alone or cotransfected with c-myc-ChREBP and sorcin-HA and incubated at low or high glucose concentrations. As expected from the coimmunoprecipitation experiments presented above, ChREBP and sorcin immunoreactivities extensively colocalized, especially at low glucose concentrations (Fig. 2B) . Strikingly, however, sorcin overexpression greatly diminished the abundance of ChREBP staining in the nucleus from 25.7 6 2.1% in the control cells to 9.4 6 0.8% in the sorcin overexpressed cells (P , 0.005, Fig. 2C ), suggesting that sorcin may serve as a cytosolic anchor for ChREBP. This was also observed in cell fractionation experiments where sorcin overexpression reduced ChREBP immunoreactivity in the nuclear compartment of cells incubated in elevated glucose concentration (Fig. 2D) . Moreover, sorcin overexpression significantly reduced the activity of the 2183L-PK and TXNIP promoters, two well-characterized ChREBP target genes (6, 9) in luciferase reporter assays, whereas a truncated L-PK promoter (2148L-PK), lacking the ChREBP binding site, was unaffected by sorcin (Fig. 2E) .
We next examined the effects of sorcin silencing on ChREBP binding to the L-PK promoter by chromatin immunoprecipitation (ChIP) and subcellular localization in response to glucose. Using siRNA, we achieved a reduction of ;86% of sorcin immunoreactivity (Fig. 3A and B) . As reported previously (6), glucose (30 vs. 3 mmol/L) stimulation increased ChREBP binding on the proximal L-PK promoter (Fig. 3C, top panel) . In contrast, in sorcinsilenced cells, ChREBP binding to the L-PK promoter was constitutive, irrespective of glucose concentrations (Fig.  3C , bottom panel, and Fig. 3D for quantification) . Accordingly, inactivation of sorcin by RNAi led to an increase in the number of cells displaying nuclear ChREBP-EGFP fluorescence at resting (3 mmol/L) glucose concentration (83.3 6 2.9% vs. 23.3 6 4.0%, P , 0.001; Fig. 3E and F) .
These ] cyt = 108 6 11 nmol/L) elicited by 250 mmol/L extracellular ATP, an activator of G proteincoupled P2 purinergic receptors (32), led to robust cytosolnuclear shuttling of ChREBP in the absence of extracellular Ca 2+ ( Fig. 4D and H and Supplementary Movie 4), suggesting that mobilization of intracellular Ca 2+ stores was sufficient for translocation. Apparently, nuclear translocation of ChREBP also depended upon the presence of elevated concentrations (30 mmol/L) of glucose ( Fig. 4E and Supplementary Movie 5), but this largely reflected the increased Ca 2+ release (D [Ca 2+ ] cyt = 31 6 7 nmol/L at low vs. 108 6 11 nmol/L at high glucose) in these conditions (Fig. 4H) . ] cyt = 234 6 20 nmol/L for control vs. 254 6 18 nmol/L for sorcin-siRNA; Fig. 4I ). Sorcin knockdown inhibits GSIS. We next examined the impact of sorcin inhibition on GSIS. As shown in Fig. 5 , sorcin silencing significantly decreased GSIS in pancreatic MIN6 b-cells. Calcium influx is required to cause ChREBP nuclear translocation in primary mouse b-cells in response to glucose. We next examined the effects of Ca 2+ influx and sorcin in primary b-cells. Dissociated CD1 mouse islets were transduced with c-myc-tagged ChREBP-expressing adenoviral particles (5) for 48 h and incubated overnight in 3 mmol/L glucose and thereafter in 3 or 17 mmol/L glucose KRBH containing either 1.5 mmol/L CaCl 2 or 10 mmol/L EGTA for 30 min before immunostaining and imaging as described in RESEARCH DESIGN AND METHODS. The identity of the b-cells was established by simultaneous immunostaining with insulin antibody. As shown in Fig. 6 , inhibiting Ca 2+ influx also abolished ChREBP nuclear localization in response to glucose. Sorcin controls ChREBP subcellular location in primary mouse b-cells. Extending the physiological relevance of the above findings, sorcin overexpression in dissociated primary mouse islets (comprising 70-80% b-cells) (33) diminished endogenous ChREBP nuclear immunoreactivity from 28.6 6 1.5% in control cells to 16.5 6 1.0% in sorcin overexpressing cells incubated in elevated (17 mmol/L) glucose (P , 0.001, Fig. 7A and B) . Conversely, sorcin silencing increased endogenous ChREBP nuclear staining to 25.5 6 1.4% compared with 13.6 6 1.1% in control cells (P , 0.001, Fig. 7C and D) , incubated in low (3 mmol/L) glucose.
DISCUSSION
The chief goal of the current study was to elucidate the molecular mechanisms through which elevated glucose concentrations lead to the nuclear accumulation of ChREBP in the pancreatic b-cell. We show that sorcin provides a Ca 2+ -regulated cytosolic anchor, likely to play an important role in the regulation of this process in both clonal and primary b-cells.
In the liver, glucose-dependent ChREBP nuclear translocation is subject to a series of phosphorylation/ dephosphorylation reactions. In fasting and in low glucose conditions, ChREBP is phosphorylated by PKA on S196 and T666 and by AMP-activated protein kinase on S568, which promote cytosol retention and inhibit DNA binding. By contrast, in high glucose conditions, protein phosphatase 2A activation by xylulose 5-phosphate (34) induces dephosphorylation of S196, T666, and S568; nuclear import; and DNA binding (35, 36) . Dephosphorylation of these residues, however, was not sufficient for ChREBP nuclear translocation in the glucose-responsive pancreatic b-cell line INS1 (832/13) (13). This is unsurprising, since, in the pancreatic b-cell, elevated glucose concentrations are rather associated with protein phosphatase 2A inhibition (37, 38) and increased intracellular cAMP levels and PKA signaling (39, 40) , pointing to the existence of additional mechanisms, possibly including the inhibition by glucose of AMP-activated protein kinase (41) .
Here we show that, in the excitable pancreatic b-cell, elevated glucose concentrations provoke ChREBP nuclear translocation through stimulation of Ca 2+ influx. Thus, extracellular Ca 2+ chelation with EGTA or pharmacological blockade of Ca 2+ entry with diazoxide or nifedipine completely abolished glucose-induced ChREBP nuclear shuttling, both in clonal MIN6 (Fig. 4) and primary mouse b-cells (Fig. 6) . Conversely, mobilization of intracellular Ca 2+ with extracellular ATP was sufficient to cause ChREBP nuclear translocation. Together, these data point to a central role for [Ca 2+ ] cyt in this phenomenon. Critically, we show that overexpression or silencing of sorcin in clonal (Fig. 2-4) or primary (Fig. 7) ] cyt have been reported previously to be detected and decoded as nuclear events via mechanisms involving cytosol-nuclear translocation of nuclear factor activator of transcription and nuclear factor-kB cells (NF-kB) (42) . The signaling module reported here may represent a similar system, which allows highly localized changes in cytosolic Ca 2+ , perhaps close to the ER or even a specific Ca 2+ release channel, to be decoded as a transcriptional response. We thus propose a model (Fig. 8 Other interesting findings of this study are the apparent depletion of intracellular Ca 2+ stores (Fig. 4I ) and the inhibition of GSIS (Fig. 5 ) after sorcin silencing in MIN6 cells. The absence of sorcin may lead to a depletion of intracellular Ca 2+ stores by allowing random activation of RyR (21) . Another possibility would be a change in gene expression, possibly the expression of the G protein-coupled P2 purinergic receptors, hence diminishing the response to extracellular ATP. However, any such changes were apparently efficiently countered by modifications to Ca 2+ pumping since neither resting nor glucose-stimulated increases in cytosolic Ca 2+ were perturbed by the knockdown of sorcin (Fig. 4I) . It follows that the interaction of sorcin with voltage-dependent (L-type) Ca 2+ channels (20) in the b-cell may be of limited importance in the control of Ca 2+ influx. The latter observation argues against substantial changes in b-cell glucose metabolism or in cellular viability after sorcin silencing in the short period (48 h) of our study. However, a chronic sorcin inhibition is likely to induce changes in gene expression through a constitutive ChREBP signaling pathway, including downregulation of ARNT/HIF1b (5) and upregulation of TxNIP (9) . Although the latter is often associated with oxidative stress and cell death by mechanisms involving mitochondrial Ca 2+ accumulation (44), we would note that the possible depletion of ER Ca the magnitude of any proapoptotic effects of TxNIP induction. Further detailed studies will be required in the future to discriminate between these possibilities.
An event distal to increase in [Ca 2+ ] cyt is therefore likely to be involved in the inhibition of GSIS. This may, for example, include the less efficient mobilization or fusion of secretory granules with the plasma membrane in sorcinsilenced cells (46) .
An exciting corollary of the work presented here is the development of novel therapeutic approaches involving sorcin activators or sorcin overexpression in the treatment of failing b-cells in type 2 diabetes, which may complement the positive action of such agents in the heart (47, 48) .
